Inﬂuence of a family history of breast and/or ovarian cancer on breast cancer outcomes

Cao,A-Yong; He,Min; Di,Gen-Hong; Wu,Jiong; Lu,Jin-Song; Liu,Guang-Yu; Shen,Zhen-Zhou; Shao,Zhi-Ming

doi:10.3892/etm.2011.275

Inﬂuence of a family history of breast and/or ovarian cancer on breast cancer outcomes

Authors:
- A-Yong Cao
- Min He
- Gen-Hong Di
- Jiong Wu
- Jin-Song Lu
- Guang-Yu Liu
- Zhen-Zhou Shen
- Zhi-Ming Shao
View Affiliations

Affiliations: Breast Cancer Institute, Cancer Hospital/Cancer Institute, Department of Oncology, Shanghai Medical College, Institutes of Biomedical Science, Fudan University, Shanghai, P.R. China
Published online on: May 26, 2011 https://doi.org/10.3892/etm.2011.275
Pages: 917-923

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Various published studies have been inconclusive in attempting to relate a family history of breast and/or ovarian cancer (BOC) to the survival of breast cancer patients. The aim of the study was to investigate the association of a family history of BOC with tumor characteristics, treatment response and the difference between the prognosis of familial breast cancer (FBC) patients and sporadic breast cancer (SBC) patients. Data on 348 operable FBC patients and 345 SBC patients were retrospectively analyzed. The overall survival (OS) and recurrence/metastasis-free survival (RFS) were compared for both groups. FBC cases were diagnosed at a relatively younger age (51.1±10.4 vs. 53.7±11.0 years, P=0.054) and presented a lower T stage (P=0.000) than the SBC cases. Patients with a family history of BOC had a signiﬁcantly greater risk of recurrence/metastasis (P=0.04) and a non-signiﬁcantly increased risk of death (P=0.06) compared to the SBC patients. In a multivariate analysis, family history of BOC was an independent predictive factor for both recurrence/metastasis rate (P=0.01, HR=0.012, 95% CI 0.02-0.57) and mortality (P=0.044, HR=0.43, 95% CI 0.19-0.98) in the hormone receptor-positive population. Our results found that women diagnosed with FBC had an early onset of disease in the population studied, and the poor outcome of patients with a family history of BOC associated with survival was restricted to the hormone receptor-positive population.

View Figures

View References

1.	Cao AY, Hu Z and Shao ZM: Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China. Breast Cancer Res Treat. 120:271–272. 2010. View Article : Google Scholar : PubMed/NCBI
2.	Campeau PM, Foulkes WD and Tischkowitz MD: Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 124:31–42. 2008. View Article : Google Scholar : PubMed/NCBI
3.	Easton DF: Familial risks of breast cancer. Breast Cancer Res. 4:179–181. 2002. View Article : Google Scholar : PubMed/NCBI
4.	Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR and Rubens RD: Family history and survival in premenopausal breast cancer. Br J Cancer. 77:2252–2256. 1998. View Article : Google Scholar : PubMed/NCBI
5.	Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G, Fioretta G, Sarp S, Sappino AP, Schubert H and Bouchardy C: Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer. 94:231–238. 2006. View Article : Google Scholar : PubMed/NCBI
6.	Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli Del Turco M and Cardona G: Does family history influence survival in breast cancer cases? Int J Cancer. 99:427–430. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Chun J, Pocock B, Joseph KA, El-Tamer M, Klein L and Schnabel F: Breast cancer risk factors in younger and older women. Ann Surg Oncol. 16:96–99. 2009. View Article : Google Scholar : PubMed/NCBI
8.	Meiser B, Tucker K, Friedlander M, Barlow-Stewart K, Lobb E, Saunders C and Mitchell G: Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res. 10:2162008. View Article : Google Scholar
9.	Nomizu T, Tsuchiya A, Kanno M, Katagata N, Watanabe F, Yamaki Y, Abe R and Miki Y: Clinicopathological features of hereditary breast cancer. Breast Cancer. 4:239–242. 1997. View Article : Google Scholar : PubMed/NCBI
10.	Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN and Arun BK: Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol. 26:4282–4288. 2008. View Article : Google Scholar : PubMed/NCBI
11.	Hamann U and Sinn HP: Survival and tumor characteristics of German hereditary breast cancer patients. Breast Cancer Res Treat. 59:185–192. 2000. View Article : Google Scholar : PubMed/NCBI
12.	Moller P, Evans DG, Reis MM, Gregory H, Anderson E, Maehle L, Lalloo F, Howell A, Apold J, Clark N, Lucassen A and Steel CM: Surveillance for familial breast cancer: differences in outcome according to BRCA mutation status. Int J Cancer. 121:1017–1020. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A and Blackwell KL: Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 26:3324–3330. 2008. View Article : Google Scholar : PubMed/NCBI
14.	Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK, Oh SK, Choe KJ and Noh DY: Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer. 4:822004. View Article : Google Scholar : PubMed/NCBI
15.	Livi L, Meattini I, Saieva C, Borghesi S, Scotti V, Petrucci A, Rampini A, Marrazzo L, Di Cataldo V, Bianchi S, Cataliotti L and Biti G: The impact of young age on breast cancer outcome. Eur J Surg Oncol. 36:639–645. 2010. View Article : Google Scholar : PubMed/NCBI
16.	Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA and Ko CY: Do young breast cancer patients have worse outcomes? J Surg Res. 113:109–113. 2003. View Article : Google Scholar : PubMed/NCBI
17.	Jobsen JJ, Meerwaldt JH and van der Palen J: Family history in breast cancer is not a prognostic factor? Breast. 9:83–87. 2000. View Article : Google Scholar : PubMed/NCBI
18.	Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O'Malley F, Andrulis IL and Goodwin PJ: Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Res Treat. 105:69–80. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Tang LC, Yin WJ, Di GH, Shen ZZ and Shao ZM: Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients. Breast Cancer Res Treat. 122:95–104. 2010. View Article : Google Scholar
20.	Dawood S, Broglio K, Buzdar AU, Hortobagyi GN and Giordano SH: Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol. 28:92–98. 2010. View Article : Google Scholar : PubMed/NCBI
21.	Murff HJ, Spigel DR and Syngal S: Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 292:1480–1489. 2004. View Article : Google Scholar : PubMed/NCBI
22.	Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA and Lynch HT: Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 77:697–709. 1996. View Article : Google Scholar : PubMed/NCBI
23.	Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L and Offit K: BRCA-associated breast cancer in young women. J Clin Oncol. 16:1642–1649. 1998.PubMed/NCBI
24.	Slattery ML, Berry TD and Kerber RA: Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology. 4:543–548. 1993. View Article : Google Scholar : PubMed/NCBI
25.	Malone KE, Daling JR, Weiss NS, McKnight B, White E and Voigt LF: Family history and survival of young women with invasive breast carcinoma. Cancer. 78:1417–1425. 1996. View Article : Google Scholar : PubMed/NCBI
26.	Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-Caspar I and Bouchardy C: Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer. 41:1446–1452. 2005. View Article : Google Scholar : PubMed/NCBI
27.	Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL and Blijham GH: Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat. 43:217–223. 1997. View Article : Google Scholar : PubMed/NCBI